Monoclonal antibodies and the midterms
Jan 27, 2022•11 min
Episode description
Republicans are accusing the Biden administration of racism — against white people. The FDA recommended that race and ethnicity be considered when deciding who gets the limited supply of monoclonal antibody treatments — including the only antibody treatment to effectively work against the Omicron variant. But, it's now become the latest political talking point for Republicans, looking to energize their base ahead of the midterm elections. Megan Messerly reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices
For the best experience, listen in Metacast app for iOS or Android
